Honglin Luo

About

Professor Honglin Luo is a faculty member at the University of British Columbia in Canada. His research primarily focuses on the molecular mechanisms behind viral myocarditis, cancer immunotherapy, and the interplay between innate immunity and autophagy. Recent publications include studies on the therapeutic implications of cellular protein quality control and the development of personalized cancer nanovaccines. Additionally, he investigates mitochondrial injury and complement dysregulation in pathological inflammation.